GlycoMimetics, Inc. (GLYC): $2.23

0.07 (+3.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GLYC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 493

in industry

Glycomimetics Inc (GLYC) Price Targets From Analysts

Use the tables below to see what analysts covering Glycomimetics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $15 $3 $10.25 $2.28 349.56%

The Trend in the Analyst Price Target


Over the past 355 days, GLYC's average price target has gone up $0.5.

GLYC reports an average of 206.01% for its upside potential over the past 355 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-03 4 15 3 10.25 2.40 327.08%
2021-04-25 4 15 3 10.25 2.52 306.75%
2021-04-12 4 15 3 10.25 2.59 295.75%
2021-04-10 4 15 3 10.25 2.89 254.67%
2021-04-03 4 15 3 10.25 3.17 223.34%
2021-03-20 4 15 3 10.25 3.45 197.1%
2021-02-15 4 15 3 10.50 4.03 160.55%
2021-02-13 4 15 3 10.50 4.03 160.55%
2021-02-06 4 15 3 10.50 4.08 157.35%
2021-01-30 4 15 3 10.50 3.63 189.26%
2021-01-23 4 15 3 10.50 3.89 169.92%
2020-12-09 4 15 3 10.50 3.50 200%
2020-12-07 4 15 3 9.00 3.80 136.84%
2020-11-06 4 15 3 9.00 2.98 202.01%
2020-10-14 4 15 4 9.25 3.43 169.68%
2020-07-31 4 15 4 9.25 3.94 134.77%
2020-05-13 4 16 4 9.75 3.08 216.56%

GLYC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 3 1 0 0 5

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Glycomimetics Inc's variance in analysts' estimates is lower than 2.63% of all US stocks.
  • GLYC has a greater upside potential (average analyst target price relative to current price) than 96.21% of all US stocks.
  • GLYC has a higher average analyst price target than 20.46% of all US stocks.
  • The number of analysts covering the stock of GLYC is higher than 34.4% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, CBIO, KTRA and CNSP are the three stocks most similar to Glycomimetics Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for GLYC? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6583 seconds.